Mechanical strength and biocompatibility of ultrafine-grained commercial purity titanium by Estrin, Yuri et al.
  
 
 
 
Estrin, Yuri, Kim, Hyoun-Ee, Lapovok, Rimma, Ng, Hoi Pang and Jo, Ji-Hoon 2013, Mechanical strength 
and biocompatibility of ultrafine-grained commercial purity titanium, BioMed Research International, 
vol. 2013, Article ID: 914764, pp. 1-6. 
 
DOI: 10.1155/2013/914764 
 
 
 
 
 
 
 
 
This is the published version. 
 
©2013, The Authors 
 
Reproduced by Deakin University under the terms of the Creative Commons Attribution Licence 
 
 
 
 
 
 
 
 
 
 
Available from Deakin Research Online: 
 
http://hdl.handle.net/10536/DRO/DU:30075986 
 
 
 
 
 
Hindawi Publishing Corporation
BioMed Research International
Volume 2013, Article ID 914764, 6 pages
http://dx.doi.org/10.1155/2013/914764
Research Article
Mechanical Strength and Biocompatibility of Ultrafine-Grained
Commercial Purity Titanium
Yuri Estrin,1,2 Hyoun-Ee Kim,2 Rimma Lapovok,1 Hoi Pang Ng,1 and Ji-Hoon Jo2
1 Centre for Advanced Hybrid Materials, Department of Materials Engineering, Monash University, Clayton, VIC 3800, Australia
2WCU Hybrid Materials Program, Department of Materials Science and Engineering, Seoul National University,
Seoul 151-744, Republic of Korea
Correspondence should be addressed to Yuri Estrin; yuri.estrin@monash.edu
Received 3 April 2013; Accepted 6 June 2013
Academic Editor: Salvatore Sauro
Copyright © 2013 Yuri Estrin et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The effect of grain refinement of commercial purity titanium by equal channel angular pressing (ECAP) on its mechanical
performance and bone tissue regeneration is reported. In vivo studies conducted on New Zealand white rabbits did not show an
enhancement of biocompatibility of ECAP-modified titanium found earlier by in vitro testing. However, the observed combination
of outstanding mechanical properties achieved by ECAP without a loss of biocompatibility suggests that this is a very promising
processing route to bioimplant manufacturing. The study thus supports the expectation that commercial purity titanium modified
by ECAP can be seen as an excellent candidate material for bone implants suitable for replacing conventional titanium alloy
implants.
1. Introduction
Titanium alloys take a prominent place among the materials
used for medical implants, particularly in bone replacement
and dental implantology [1–5]. However, concerns about
possible biotoxicity of alloying elements, such as Al and V in
the popular Ti-6Al-4V alloy, have been recently driving the
development of commercial purity (CP) grades of titanium as
an alternative to alloys [6]. This is of particular significance
for dental applications, which pose stringent requirements on
biocompatibility of the implant materials [5].
If commercial purity (CP) titanium is to replace Ti alloys
as a competitive implant material, the loss of strength due
to lack of alloying elements needs to be compensated for.
The only tool the metallurgist is left with is to modify the
microstructure, and mechanical working leading to grain
refinement appears to be the only viable option. The severe
plastic deformation technique of equal channel angular
pressing (ECAP) was proposed as a potent way to achieve
strengthening of CP Ti by extreme grain refinement down to
deep submicron range [1, 7–9]. It was further shown that such
grain refinement also leads to enhanced attachment of living
cells to the surface of Ti. Indeed, in vitro tests demonstrated
that proliferation of the fibroblast [7, 8], preosteoblast [9, 10],
and stem cells [11] on the surface of ECAP-modified Ti was
markedly increased. The degree of preosteoblast attachment
and rate of growth on the surface of CP titanium was also
found to be increased as a result of grain refinement by
high-pressure torsion—another severe plastic deformation
technique [12]. The mechanisms of this effect found in vitro
are not yet understood, but the first data suggest that it is a
change in Ti surface morphology [11] and grain orientation
[12] that gives rise to the enhanced cell response.
As improved biocompatibility in vitro is no guarantee that
this favourable effect will be replicated in an in vivo situation,
we have conducted an in vivo study on the same Grade 2CP
titanium that was investigated earlier [9, 11]. In this com-
munication, we report the results of a study of the extreme
grain refinement by ECAP on the in vivo performance of the
material in an animal test. For completeness, transmission
electron microscopy and mechanical characteristics of the
material are presented.
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Figure 1: Grain structure of Grade 2CP Ti in the as-received (a) and the ECAP-modified (b) state.
2. Materials and Methods
ASTM Grade 2CP titanium (Tico Inc., USA), which was
also employed in previous work [9, 11], was investigated.
Specimens of the material in the as-received condition
(extruded bar annealed at 704.4∘C for 1 h) as well as in the
ECAP-modified state (four ECAP passes at 350∘C, route 𝐵
𝑐
involving rotation by 90∘ about the long axis between the
passes) were used. A back pressure applied made it possible
to conduct ECAP at a relatively low temperature of 350∘C
thus leading to a very substantial level of grain refinement.
A huge difference in the average grain size between these
two conditions (4.5 𝜇m for the as-received and ca. 200 nm
for the ECAP-modified state) is seen from the micrographs
in Figure 1.
This difference in microstructure is responsible for a
very strong difference in the tensile deformation behaviour
presented in Figure 2. The magnitude of the ultimate tensile
strength (about 850MPa) is in excess of what has ever been
achieved for Grade 2CP Ti by ECAP processing only, that is,
without any postprocessing steps [13].
The mechanisms of extreme grain refinement by severe
plastic deformation by formation of dislocation cell arrange-
ment, which gradually transforms into a new, finer, grain
structure upon continued straining, are understood reason-
ably well [14], as is an inverse correlation between the tensile
strength and the grain size. Using a rather robust relation
applicable to ultrafine-grained titanium and its alloys [15],
the expected fatigue strength (i.e., the stress amplitude cor-
responding to 107 fatigue cycles) can be estimated roughly as
half the ultimate tensile strength,which yields a value of about
425MPa. While tensile ductility had to be partly sacrificed
to gain these levels of strength (which are comparable with
those for conventional, coarse-grained Ti-6Al-4V alloy), the
remaining value of elongation to failure of about 20% is
sufficiently high for biomedical applications in sight.
As reported earlier [9], the ECAP processing and the
concomitant changes in the grain size of the bulk and the
morphology of the polished surface of this Grade 2CP
titanium yielded a spectacular (nearly 20-fold!) gain in the
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Figure 2: Uniaxial stress-strain curves for the as-received coarse-
grained (CG) and ECAP-modified ultrafine-grained (UFG) Grade
2CP Ti.
proliferation rate of preosteoblast cells as observed in vitro. A
recent study of the response of human bone marrow-derived
mesenchymal stem cells (hMSCs) to the same material
showed that the attachment and spreading of hMSCs within
the first 24 h of in vitro culturing was markedly accelerated
on the surface of the ECAP-modified material [11]. Along
with the observation of accelerated proliferation of bacteria
on ECAP-modified CP Ti [16], these findings indicate clearly
that ECAP processing leads to enhanced bioactivity of tita-
nium. These findings are in line with the general trend of
nanostructuring being a promoter of improved cell adhesion
to and proliferation on titanium [3, 12, 17].
With this promise in mind, we have conducted an animal
test aiming at an assessment of the extreme grain refinement
by ECAP on the in vivo biocompatibility of Grade 2CP
titanium. Indeed, it is not uncommon that the in vivo
behaviour of a candidate implant material is different from
the in vitro response [18]. In another context, Toledo and
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Figure 3: Low-voltage SEM micrographs of the space between the ridges on the threaded parts of as-received (a) and ECAP (b) titanium
screws.
Proximal
DistalScrews used in
this study
Figure 4: Titanium screws implanted in the rabbit tibia. (Right: CT
scan.)
Wahlmade this point through a pun in the title of their review
paper: “in vitro hypothesis, in vivo veritas” [19].
Four New Zealand white rabbits were used as test objects.
Screws made from the as-received and the ECAP-modified
titanium were CNC machined and implanted in the tibia of
the hind legs of a rabbit after ultrasonic cleaning in a distilled
water bath for 1 h and sterilisation by 𝛾-radiation. Figure 3
shows the surface morphologies of the screws imaged by
Figure 5: 3D micro-CT scan of bone tissue grown on a screw
from ECAP-modified titanium. The sketch in the insert defines the
volume of interest (VOI) delineated by the red dashed line.
a JEM-7001F FEG scanning electron microscope (SEM)
operated at 5 kV. The machined surfaces of the as-received
and ECAP-modified screws were characterised by a dense
array of circumferential grooves, each having a width in the
range of 80–110 nm. High resolution edge-on images of the
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Figure 6: 2D histology images of bone tissue growth on the implanted titanium screws. (a) As-received titanium; (b) ECAP-modified
titanium.
screw surface profile further revealed that these nanoscale
grooves typically had a peak-to-peak distance of the order
of tens of nanometres. No significant difference could be
identified between the two types of screws in terms of
the extent of roughness in the micron-to-submicron range,
that is, the microroughness. The animals were anesthetised
with a combination of 1.5 cc of 2% xylazine HCl (Rompun,
Bayer Korea) and 0.5 cc of tiletamine HCl (Zoletil, Virbac
Laboratories, France) and lidocaine (Yuhan Corporation,
Republic of Korea). Additionally, 1 : 100,000 epinephrine was
injected for the local anesthesia. Two defects were made on
each tibia using a 3mm diameter trephine drill. The screw
samples were implanted into the tibial bone defects. After the
surgery, the wounds were sutured with Surgisorb (Samyang
Ltd., Republic of Korea), and then cephradine (Bayer Korea),
an antibiotic, was injected into the rabbit for 3 days. Only the
screws implanted in the lower (distal) portion of the tibia,
where the cortical bone thickness was sufficiently uniform,
were used in the present test. (The screws implanted in the
upper (proximal) parts of the tibia were not suitable, as
the cortical bone thickness is not sufficiently uniform there.
Thesewere used for separate tests not reported here.)Hence, a
total of four screws of each kind were investigated (Figure 4).
While this cannot be considered as a statistically large sample,
the animal ethics considerations had priority, and only four
animalswere sacrificed for the test.Theywere euthanised four
weeks after surgery. The test was carried out in compliance
with the strict animal ethics regulations of the Seoul National
University.
3. Results and Discussion
After four weeks of implantation, bone growth was inspected
by histological and microtomography study. The samples
were scanned using amicro-CT (Skyscan 1173 X-rayMicroto-
mography System, Skyscan, Belgium) at a resolution of 12𝜇m,
a voltage of 130 kV, and a current of 40𝜇A.Theobtained scans
were used for 3D reconstruction by means of a commercial
program. The implant and the bone tissue were observed
using Data Viewer (Skyscan, Belgium). The results of a
quantitative assessment of bone tissue growth on the screws
made from the as-received and the ECAP-modified titanium
are presented in two ways. (i) The regenerated bone volume
calculated using micro-CT scans (Skyscan 1173 X-ray Micro-
tomography System, Skyscan, Belgium) is shown in Figure 5.
This quantity is defined as the ratio of the bone tissue volume
within the volume of interest (VoI, specified in the insert in
Figure 5) to the difference between the VoI and the volume
of the implant material therein. It is expressed in percent. (ii)
In addition, the bone-implant contact (BIC), also expressed
in percent, was calculated using histological images. After
micro-CT scans, the extracted bone samples were fixed in
a neutral 10% formaldehyde solution, and the tissue blocks
were embedded in a resin for histological analysis. The
blocks were cut into sections and the microscopic images
of the trichrome and haematoxylin-eosin stained sections
were obtained using Axioskop microscopy (Olympus BX51,
Olympus Corporation, Tokyo, Japan). Representative 2D
histological sections are shown in Figure 6.
From these histological images, the BIC ratios were
calculated, along with the bone volume, using a digital image
analysis program (SPOT, Diagnostic Instruments Inc., MI,
USA). Hence, the bone volume was obtained both by micro-
CT and by histological investigations, while BIC was derived
only by histology—arguably the more appropriate technique
for determining this measure of bone regeneration. The
appearance of the spreading of the bone tissue into the root
space of the screw thread (Figure 6) suggests that cell bone
attachment and proliferation are qualitatively similar for both
screw materials. This is supported by quantitative data; see
below.
The diagrams showing the results of micro-CT and histo-
logical analysis in terms of these two quantitativemeasures of
bone growth are presented in Figures 7 and 8. Due to the large
scatter in the data and a small sample of only four implants
in each condition investigated, one cannot establish with
certainty which of the two conditions leads to a higher level
of bone growth. In terms of their response to cell attachment
and proliferation, both types of screws were largely the same.
The absence of any major difference in biocompatibility
between the two types of screws can be attributed to their
striking similarity with respect to the microroughness of the
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Figure 7: Bone volume (as defined in the text) for the as-received
and ECAP-modified titanium screws.
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Figure 8: Bone-implant contact (BIC) for the as-received and the
ECAP-modified titanium screws.
machined surface—despite a very large difference between
the as-received and the ECAP-modified screws in grain size
in the bulk (4.5𝜇m versus 200 nm).
In earlier research, nano- or submicron scale surface
topography features were shown to play a crucial role in the
adhesion and proliferation of bone cells on titanium [20].The
well-polished surfaces in our previous in vitro assays [9, 11, 16]
tended to inherit some features of the ultrafine crystallinity
of the bulk produced by severe plastic deformation of the
material. This kind of surface topography was shown [20] to
have a favourable effect on the attachment and proliferation
of osteoblast cells—although the exact mechanism for the
effect is yet to be uncovered. However, as suggested by SEM
results (Figure 3), this difference in surface topography was
apparently lost in the process of machining of the implants,
so that no significant difference in the in vivo cell response to
the implantsmade fromcoarse-grained and ultrafine-grained
Ti was observed.
Assuming no significant differences in surface chemistry
of the initial and the ECAP-modifiedmaterial are introduced
by machining, the similarity in surface topography of the
machined implants can be seen as the reason for cellular
response to the implants not being distinctly different in vivo.
Nonetheless, even though the present in vivo tests did not
show enhanced cell response to ECAP-modified implants
found earlier by in vitro assays [9], it is fair to say that the
screws made from ECAP-modified Ti are on par with their
counterparts made from the as-received material.
4. Conclusions
The results of the in vivo tests show that ECAP processing
does not live to the expectations of significant enhancement
of bone tissue growth raised by the in vitro studies [9].
However, one should not be discouraged by the outcomes of
the animal tests. Indeed, the present study has shown that the
strength level of about 850MPa, which is exceptionally high
for Grade 2 titanium, can be achieved by ECAP processing
without a loss in osseointegration capability of the implants.
Thus, this study has demonstrated that the improvement of
themechanical performance of CP titanium by equal channel
angular pressing does not compromise its biocompatibility
in a real in vivo situation. Considering the notion that the
surface topography of an implant has a crucial effect on cell
attachment, possible correlation between bulk microstruc-
ture and surface topography of titanium is of practical interest
and thus warrants further investigation. Machined implants
commonly undergo further surface treatment before actual
implantation [21]. The effect of the various surface treatment
processes, to which the initial and the ECAP-modified
titanium may or may not respond differently, is thus an
important subject for further study—both in vitro and in vivo.
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